Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The protein sequencing market is strongly influenced by the growth of the biopharmaceutical industry. As the demand for biologic drugs and personalized medicine rises, there is an increased need for accurate protein sequencing, driving market expansion.
New developments in proteomics research have continued to transform protein sequencing market. With continuous research into proteins functions and structures, the need for more powerful high-throughput sequencing technologies is likely to increase which in turn influences market trends.
There is a high demand for protein sequencing because there has been lots of focus on developing drugs especially in biopharmaceutical industries. The elucidation of proteins serves as an important milestone in the process of drug development by encouraging protein sequencing technologies.
Improvement in sequencing platforms leads to efficient and precise protein identification. The development of next-generation sequencing technologies and the evolving mass spectrometry lead to changes in this market that attract investments and shape a competitive environment.
Protein sequencing is proving useful in clinical diagnostics, fueling the development of its market. The wider scope of market application is also enabled by accurate protein sequencing that allows the identification disease-specific protein markers and targets specific therapies.
Collaborations between research institutes and corporations affect the market dynamics. Such collaborations typically result in the emergence of novel sequencing technologies and methodologies, impacting their usage trends within academe as well as among commercial entities.
Government initiatives and funding support for proteomics research is driving market growth. The provision of financial support for projects on protein sequencing technologies lures the adoption of state-of-the art platforms and procedures.
The development of precision medicine programs, in which medical treatment is individualized based on patient characteristics increases the requirement for accurate protein sequencing. Personalized treatment strategies also help determine market trends by revealing individuals’ unique protein profiles.
Demands for protein sequencing are driven by academic research focusing on the structural and functional aspects of proteins. Universities and research institutions have a crucial role in widening the market for proteins because they investigate, among other things, protein biology.
Biotechnology investments affect the protein sequencing market. Companies engaged in the production of therapeutic proteins, biosimilars and other biologics form a large market for robust protein sequencing technologies that drive demand thereby leading to steady growth rate.
The heightening of complexity in protein therapeutics such as monoclonal antibodies and fusion proteins demands sophisticated methods for the sequencing of proteins. The market is formed by the demand to describe complex protein structures for regulatory approval and production in detail.
Market dynamics are affected by the overproduction of contract research organizations providing protein sequencing. The adoption of sequencing services is also affected by CROs, which pharmaceutical and biotechnology companies hire to receive specialized expertise.
Globalization of biopharmaceutical research has been the main driving factor behind market growth. With the increased research and development activities across borders, the need for standardized and high-quality protein sequencing technologies increases making this market grow.
The cost-effectiveness of protein sequencing solutions is a critical factor influencing market adoption. Affordable and efficient sequencing technologies make protein analysis accessible to a broader range of users, including smaller research laboratories and academic institutions.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Growth Rate | Â 3.89% |
Protein Sequencing Market Highlights:
Global Protein Sequencing Market Overview
Protein Sequencing Market Size was valued at USD 0.8 Billion in 2023. The Global Protein Sequencing industry is projected to grow from USD 0.85 Billion in 2024 to USD 1.34 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 3.89% during the forecast period (2024 - 2032).
Protein sequencing technologies are used to determine and analyze the amino acid sequences of proteins or peptides. Increased focus on target-based medication development by biotechnology and pharmaceutical companies, as well as increased financial support for proteome research from the public and commercial sectors.
Advancements in clinical mass spectrometry and analytical techniques are some of the factors that are expected to drive market growth during the forecast period. The National Cancer Institute Office of Cancer Clinical Proteomics Research, for example, offers funding options for proteomics research. However, the high cost of infrastructure and equipment may limit the expansion of the protein sequencing market over the assessment period.
Thermo Fisher Scientific, the largest life sciences company worldwide, and Olink Holding, a leading provider of next-generation proteomic solutions, announced on October 17th, 2023, that their respective boards have approved the proposal of Thermo Fisher to acquire Olink at a price of US$26.00 per common share in cash or US$26.00 per American Depository Share (ADS) in cash.
American manufacturer of scientific instruments Bruker Corporation announced on June 5th, 2023, that it drastically increased the sensitivity of its timsTOF platform for 4D-Proteomics with the introduction of the new times of Ultra mass spectrometer including a novel Capillary Spray Ionization (CSI) ultra source with large capillary and optimized vortex gas flow as well as a newly designed fourth generation TIMS XR (trapped ion mobility separation) cell and 14bit digitizer.
In December 2022, Quantum-Si Incorporated declared launching Platinum; this is considered the world’s first-ever novel next-generation single-molecule protein sequencing platform.
In September 2022 NVIDIA Corporation promised to integrate NeMo LLM cloud services through BioNeMO so as to allow for biological and chemical pre-trained language models access by academics. The services facilitate research interaction while manipulating data plus proteins for various applications such as drug discovery.
Amphista Therapeutics, which seeks to develop small molecule protein degraders and Bristol Myers Squibb entered into partnership in May 2022. There is likely going to be an exclusive license for production and marketing, given that product.
For instance, researchers from the University of Texas in January 2022 revealed a practical way towards single-molecule protein sequencing. Thus, market growth will result due to technological advances in protein-sequencing techniques.
Collaboration between Amgen and Generate Biomedicines was given birth in January 2022 for the discovery and development of protein-based therapies across multiple areas. The deal is expected to cost around USD 1.9 billion.
Protein Sequencing Segment Insights
The protein sequencing market has been segmented into products and services, technology, application, and end user.
Protein Sequencing Products and Services Insights
By products and services, the market has been segmented into reagent and consumables, instruments, analysis products/software, and protein sequencing services. The instrument segment has been further segmented into mass spectrometry instruments and Edman degradation sequencers. The reagents and consumables segment accounted for the largest share of the protein sequencing products market in 2017. The factors such as ongoing advancements in protein sequencing technologies and the rising number of sequencing procedures are expected to boost the growth of the segment.
Protein Sequencing Technology Insights
On the basis of technology, the market has been segmented into mass spectrometry and Edman degradation.
Protein Sequencing Application Insights
On the basis of application, the market has been segmented into biotherapeutics, genetic engineering, and others. The biotherapeutics segment is anticipated to be the fastest growing segment during the forecast period.
Protein Sequencing End User Insights
The market, by end user, has been segmented into pharmaceutical and biotechnology companies, academic institutes and research centers, and others.
Protein Sequencing Regional Insights
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The protein sequencing market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European protein sequencing market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The protein sequencing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The protein sequencing market in the Middle East and Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Geographically, the Americas is anticipated to dominate the global protein sequencing market owing to the rising application of protein sequencing in proteomic research, the development of protein sequencing, and availability of research funding in the region. For instance, in September 2016, the National Institute of Health (NIH) announced to fund for research on Proteomics, Immunoassay for TB Activation in HIV Patients.
Europe is expected to hold the second largest position in the global protein sequencing market. The market growth in this region is attributed to the increasing proteomics research and the availability of funding and infrastructure for research. For instance, PRIME-XS is a consortium of 12 European research institutes. It is a pan-European infrastructure for proteomics research.
The protein sequencing market in the Asia-Pacific region consists of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the Rest of Asia-Pacific. The Asia-Pacific region is expected to be the fastest growing region owing to the increase in government funding for healthcare, rising R&D expenditure, and a growing number of biopharmaceutical companies.
The Middle East and Africa has the lowest share of the global protein sequencing market. Majority of the market of the region is anticipated to be held by the Middle Eastern region owing to the growing government initiatives for the healthcare sector.
Global Protein Sequencing Market Share (%), by Region, 2022
Source: White Papers, Company Presentations, Annual Reports
Recent Development
BSI's objective is to make a positive influence in proteomic research, particularly by offering professionally supported software. Bioinformatics Solutions Inc. creates powerful algorithms based on cutting-edge research to solve basic bioinformatics difficulties. This small, agile team is dedicated to meeting the demands of pharmaceutical, biotechnological, and academic scientists, as well as advancing drug discovery research. The firm, started in 2000 in Waterloo, Canada, is comprised of a bright, award-winning, and clever crew of developers, scientists, and salespeople.
Charles River Laboratories International, Inc. offers drug discovery and development solutions such as research models and related services, as well as outsourced preclinical services. Segments the business is divided into two divisions: The firm produces and sells research models, mostly genetically and virally specified purpose-bred rats and mice, with roughly 150 distinct strains. It also offers a variety of complementary services to help clients support the usage of research models in medication development.
Intended Audience
- Protein sequencing Device Manufacturers and Distributors
- Mass Spectrometry Manufacturers and Distributors
- Pharmaceutical and Biotechnological Companies
- Contract Research Organizations
- Academic and Research Institutes
- Government Associations
Key players:
- Bioinformatics Solutions
- Charles River Laboratories
- Agilent Technologies, Inc.
- Proteome Factory
- Rapid Novor Inc.
- Selvita
- SGS
- Shimadzu Corporation
- Thermo Fisher Scientific Inc.
- Waters Corporation
are some of the key players in the global protein sequencing market.
Protein Sequencing Market Segment Analysis
Protein Sequencing Products & Services Outlook
- Reagents and consumables
- Instruments
- Mass Spectrometry Instruments
- Edman Degradation Sequencers
- Analysis Products/Software
- Protein Sequencing Services
Protein Sequencing Technology Outlook
- Mass Spectrometry
- Edman Degradation
Protein Sequencing Application Outlook
- Biotherapeutics
- Genetic Engineering
- Others
Protein Sequencing End User Outlook
- Pharmaceutical & Biotechnology Companies
- Academic Institutes & Research Centers
- Others
Protein Sequencing Regional Outlook
- Americas
- North America
- US
- Canada
- South America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
The report for Protein Sequencing Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
